Evidence map›Paper›PMID 26943180›Full record

ArticleJournal of nephrology2016

Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.

Claudio Musetti, Deepak Babu, Ileana Fusco, Simona Mellone, Andrea Zonta, Marco Quaglia, Vincenzo Cantaluppi, Piero Stratta, Mara Giordano

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Long-Read Sequencing of thebioRxiv : the preprint server for biology · 2025
    Article
  3. Clinical kidney journal · 2025
    Article
  4. Article
  5. Noninvasive Immunohistochemical Diagnosis and NovelJournal of the American Society of Nephrology : JASN · 2018
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Claudio MusettiDepartment of Translational Medicine, Nephrology and Transplantation, University Piemonte Orientale, Novara, Italy. claudio.musetti@med.uniupo.it.ORCID http://orcid.org/0000-0002-8207-6062
Deepak BabuLaboratory of Genetics, Department of Health Sciences and IRCAD, University Piemonte Orientale, Novara, Italy.
Ileana FuscoLaboratory of Genetics, Department of Health Sciences and IRCAD, University Piemonte Orientale, Novara, Italy.
Simona MelloneLaboratory of Genetics, Department of Health Sciences and IRCAD, University Piemonte Orientale, Novara, Italy.
Andrea ZontaLaboratory of Genetics, Department of Health Sciences and IRCAD, University Piemonte Orientale, Novara, Italy.
Marco QuagliaDepartment of Translational Medicine, Nephrology and Transplantation, University Piemonte Orientale, Novara, Italy.
Vincenzo CantaluppiDepartment of Translational Medicine, Nephrology and Transplantation, University Piemonte Orientale, Novara, Italy.
Piero StrattaDepartment of Translational Medicine, Nephrology and Transplantation, University Piemonte Orientale, Novara, Italy.
Mara GiordanoLaboratory of Genetics, Department of Health Sciences and IRCAD, University Piemonte Orientale, Novara, Italy.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMedullary cystic kidney disease type 1 (MCKD1; OMIM #174000) is a familial progressive tubule-interstitial nephropathy belonging to the recently defined group of autosomal dominant tubulointerstitial kidney diseases (ADTKD). CASE REPORT: A specific type of cytosine insertion in the extracellular variable number tandem repeat (VNTR) domain of the MUC1 gene causing the disease was tested in a group of 21 families with ADTKD. We identified this type of MUC1 mutation in two families, whose affected members are described in detail in this case report. Affected (ADTKD-MUC1) members developed end-stage renal disease (ESRD) with a higher incidence (p = 0.033) and at a younger age (p = 0.013) than probands with ADTKD but without this type of mutation. All patients with MUC1-associated kidney disease shared a rather unspecific tubule-interstitial laboratory pattern without medullary cysts, leading to ESRD between the age of 33 and 47 years. We were not able to identify any single common extra-renal feature among affected patients, even if they had various comorbidities, which are described in detail.

conclusionsWe identified this type of MUC1 mutation in 9.5 % of families from an ADTKD Italian cohort; larger studies are needed to better define the criteria for genetic testing for this type of mutation.

Indexed as

Minisatellite RepeatsMutagenesis, InsertionalAdultCohort StudiesCytosineHumansMaleMiddle AgedMucin-1Polycystic Kidney, Autosomal DominantCytosineMUC1 protein, humanMucin-1Autosomal-dominant tubule-interstitial kidney diseaseMalignancyMedullary cystic kidney diseaseMUC1

Identifiers

PMID26943180
OpenAlexW2289664241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.